Ameriprise Financial Inc Atossa Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $102 - $142	-125 Reduced 1.12%	11,007 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.28 $2,783 - $4,192	-3,275 Reduced 22.73%	11,132 $12,000
Q1 2022 May 16, 2022	BUY	$1.11 - $1.74 $15,991 - $25,068	14,407 New	14,407 $18,000
Q4 2021 Feb 14, 2022	SELL	$1.6 - $3.27 $47,755 - $97,599	-29,847 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $47,598 - $105,408	16,470 Added 123.12%	29,847 $97,000
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $20,333 - $115,309	13,377 New	13,377 $85,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.